CYP3A5 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018623
Fusion event
HBV-CYP3A5 integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1740
Integrated sequence
TGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGA| |GTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAA
Host Sequence
Chromosome
chr7
Cytoband
q22.1
Reference genome
End
99249678/99652055 (Hg38)
Location type
Intron2
Fragile sites / regions
Target gene
Nearest miRNA
hsa-mir-10525/Upstream/242791; hsa-mir-10399/Downstream/441505;
Upstream sequence
aaagaattttggaagcaccacatattatacaccattatatacttagaggatgcattcaccatttaactctctgagaagtcttacagtaaggaaacttgtt
Downstream sequence
AATTCAGAGAGCTAAAGGGCACAGCATAGAAAAAACAGAAAGGAATAAAAAGCCTATACACCTGAAATAACATCATGGTTAAATGGTTTATGGCATATGC
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Curate